125 related articles for article (PubMed ID: 37329551)
1. Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.
Sun L; Niu T; Zhang Y
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):31-36. PubMed ID: 37329551
[TBL] [Abstract][Full Text] [Related]
2. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
3. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
5. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
[TBL] [Abstract][Full Text] [Related]
6. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-lymphocyte Antigen-4 (
VAN Nguyen S; Shamoun L; Landerholm K; Andersson RE; Wagsater D; Dimberg J
In Vivo; 2021; 35(2):969-975. PubMed ID: 33622891
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
Chen J; Kang S; Wu J; Zhao J; Si W; Sun H; Li Y
J Obstet Gynaecol Res; 2022 May; 48(5):1240-1247. PubMed ID: 35150042
[TBL] [Abstract][Full Text] [Related]
9. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
[TBL] [Abstract][Full Text] [Related]
10. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis.
Ni J; Qiu LJ; Zhang M; Wen PF; Ye XR; Liang Y; Pan HF; Ye DQ
Endocr Res; 2014; 39(4):180-8. PubMed ID: 24697361
[TBL] [Abstract][Full Text] [Related]
12. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
[TBL] [Abstract][Full Text] [Related]
13. Correlation of CTLA-4 polymorphism and the risk of gastric cancer in a Chinese Bai population.
Yan P; Kong S; Zheng Y; Cheng M; Zhao W
Int J Immunogenet; 2023 Oct; 50(5):256-263. PubMed ID: 37495903
[TBL] [Abstract][Full Text] [Related]
14. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
Front Immunol; 2021; 12():607966. PubMed ID: 33717091
[TBL] [Abstract][Full Text] [Related]
17. Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.
Liu J; Tang W; Lin W; Wang Y; Chen Y; Wang J; Liu M; Xu W; Lin J; Zhang L
DNA Cell Biol; 2019 May; 38(5):443-448. PubMed ID: 30888206
[TBL] [Abstract][Full Text] [Related]
18. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
[TBL] [Abstract][Full Text] [Related]
19. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
[TBL] [Abstract][Full Text] [Related]
20. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
